NAD Test Expansion Opportunity to upsell or partner on biomarker panels leveraging Jinfiniti's newly launched intracellular NAD test using dried blood spots, enabling broader metabolic and aging assessments for clinical and consumer markets.

DBS Capabilities Position Jinfiniti as a specialist in dried blood spot technologies for accurate biomarker testing, offering scalable sample collection for remote or telemedicine-based health programs and employer wellness initiatives.

Small Team, Big Reach With a lean 2-10 employee base and revenue in the multi-million range, there is room to partner on channel strategies, white-labeling, or co-marketing to accelerate market penetration while leveraging their agility.

Biomarker Test Platform Cross-sell to adjacent consumer genetics and precision health players by highlighting a comprehensive biomarker testing capability that complements genetic tests from larger providers, appealing to customers seeking holistic health insights.

Growth Adjacent Markets Target sectors such as corporate wellness, direct-to-consumer health monitoring, and clinical research collaborations where data-driven biomarker insights can drive customer value and create recurring revenue streams.